Home > Analyse
Actualite financiere : Actualite bourse

Merck: Invest Securities becomes a buyer.

(CercleFinance.com) - On Tuesday Invest Securities upgraded its rating on the Merck stock from "neutral" to "buy" and has raised its target price from 96 euros to 108 euros.


The broker was reacting to last week's "Capital Market Day," which from its point of view both "reassured the market regarding the group's ability to resume growth on its "Performance Materials post-2018” franchise and to “highlight the attractiveness of its 'Pharma' pipeline, whose adjusted sales potential has been confirmed at 2 billion euros as early as 2022."

"On this latter point, there is a gap between the market's expectations and those of the company," Invest Securities said, whose initially conservative stance on the group's ability to renew its portfolio is changing at the pace of its progress.


Copyright (c) 2017 CercleFinance.com. All rights reserved.
The information and analyses distributed by Cercle Finance are only intended as decision-making support for investors. Cercle Finance's responsibility may not be entailed, either directly or indirectly following the use of such information and analyses by readers. Any non-professional investor is recommended to consult a professional advisor before making any investment decision. This indicative information in no way constitutes any invitation to sell or buy securities.